These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38165573)

  • 1. Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.
    Han Y; Maimaiti N; Sun Y; Yao J
    J Mol Histol; 2024 Feb; 55(1):139-148. PubMed ID: 38165573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Knockdown of lysine-specific demethylase 3A (KDM3A) inhibits the invasion and migration of MDA-MB-231 breast cancer cells and arrests the cell cycle in the G0/G1 phase].
    Gao W; Zhang T; Yao J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):808-814. PubMed ID: 34533128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S; Guo G; Wang CY
    Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
    Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL8A1 enhances the invasion/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression.
    Sagara A; Miura S; Kobinata A; Naganawa R; Yaginuma S; Saito S; Saito R; Kominato H; Yumoto T; Sato F
    Biochem Biophys Res Commun; 2023 Jan; 642():145-153. PubMed ID: 36577251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
    Song Y; Li L; Xi Y
    Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-155-3p attenuates intervertebral disc degeneration via inhibition of KDM3A and HIF1α.
    Zhou X; Li J; Teng J; Liu Y; Zhang D; Liu L; Zhang W
    Inflamm Res; 2021 Mar; 70(3):297-308. PubMed ID: 33486545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.
    Liu J; Liang T; Zhangsun W
    Int J Biol Macromol; 2019 Apr; 126():318-325. PubMed ID: 30578902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
    Cho HS; Toyokawa G; Daigo Y; Hayami S; Masuda K; Ikawa N; Yamane Y; Maejima K; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Int J Cancer; 2012 Aug; 131(3):E179-89. PubMed ID: 22020899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L.
    Pedanou VE; Gobeil S; Tabariès S; Simone TM; Zhu LJ; Siegel PM; Green MR
    Elife; 2016 Jul; 5():. PubMed ID: 27472901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.
    Sechler M; Parrish JK; Birks DK; Jedlicka P
    Oncogene; 2017 Jul; 36(29):4150-4160. PubMed ID: 28319067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.
    Wang W; Wang B
    BMC Cancer; 2022 May; 22(1):562. PubMed ID: 35590288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF13 promotes metastasis of triple-negative breast cancer.
    Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
    Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1.
    Yang L; Zhang Q; Yang Q
    Genes Genomics; 2022 Nov; 44(11):1333-1342. PubMed ID: 36094735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
    Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine-specific demethylase 3A is important for autophagic occurrence.
    Kim J; Choi SA; Kim J; Kim H; Baek SH
    Biochem Biophys Res Commun; 2020 May; 526(1):176-183. PubMed ID: 32201075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.